Reducing unnecessary emergency department visits and hospitalizations in the management of pediatric febrile neutropenia. This is an ASCO Meeting Abstract from the 2025 ASCO Quality Care Symposium.
NEW YORK--(BUSINESS WIRE)--Koneksa, a healthcare technology company pioneering evidence-based digital biomarkers, today announced the publication of a new multi-domain model for capturing functional ...